Denise G Tate1, Tracey Wheeler2, Giulia I Lane3, Martin Forchheimer1, Kim D Anderson4, Fin Biering-Sorensen5, Anne P Cameron3, Bruno Gallo Santacruz6,7, Lyn B Jakeman8, Michael J Kennelly9, Steve Kirshblum10, Andrei Krassioukov11, Klaus Krogh12, M J Mulcahey13, Vanessa K Noonan14, Gianna M Rodriguez1, Ann M Spungen15, David Tulsky16, Marcel W Post17,18. 1. Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan, USA. 2. Craig H Neilsen Foundation, Encino, California, USA. 3. Department of Urology, University of Michigan, Ann Arbor, Michigan, USA. 4. Department of Physical Medicine and Rehabilitation, Metro Health Medical Center, Case Western Reserve University, Cleveland, Ohio, USA. 5. Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 6. Coloplast A/S, Humlebaek, Denmark. 7. Radiometer Medical, Brønshøj, Denmark. 8. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. 9. Department of Urology, Carolinas Medical Center, Charlotte, North Carolina, USA. 10. Rutgers New Jersey Medical School, Kessler Foundation, Kessler Institution for Rehabilitation, West Orange, New Jersey, USA. 11. International collaboration On Repair Discoveries (ICORD), Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 12. Department of Clinical Medicine, Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. 13. Jefferson College of Rehabilitation Sciences, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. 14. The Praxis Spinal Institute, The Rick Hansen Institute, Vancouver, British Columbia, Canada. 15. VA RR&D National Center of Excellence for the Medical Consequences of Spinal Cord Injury, James J Peters VA Medical Center, Bronx, New York, USA. 16. Department of Physical Therapy and Psychological & Brain Sciences, University of Delaware, Newark, Delaware, USA. 17. Department of Rehabilitation Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 18. Center of Excellence for Rehabilitation Medicine, UMC Brain Center, University Medical Center Utrecht, University of Utrecht and De Hoogstraat, Utrecht, the Netherlands.
Abstract
Objective: To provide an overview of clinical assessments and diagnostic tools, self-report measures (SRMs) and data sets used in neurogenic bladder and bowel (NBB) dysfunction and recommendations for their use with persons with spinal cord injury /disease (SCI/D). Methods: Experts in SCI/D conducted literature reviews, compiled a list of NBB related assessments and measures, reviewed their psychometric properties, discussed their use in SCI/D and issued recommendations for the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements (CDEs) guidelines. Results: Clinical assessments included 15 objective tests and diagnostic tools for neurogenic bladder and 12 for neurogenic bowel. Following a two-phase evaluation, eight SRMs were selected for final review with the Qualiveen and Short-Form (SF) Qualiveen and the Neurogenic Bowel Dysfunction Score (NBDS) being recommended as supplemental, highly-recommended due to their strong psychometrics and extensive use in SCI/D. Two datasets and other SRM measures were recommended as supplemental. Conclusion: There is no one single measure that can be used to assess NBB dysfunction across all clinical research studies. Clinical and diagnostic tools are here recommended based on specific medical needs of the person with SCI/D. Following the CDE for SCI studies guidelines, we recommend both the SF-Qualiveen for bladder and the NBDS for bowel as relatively short measures with strong psychometrics. Other measures are also recommended. A combination of assessment tools (objective and subjective) to be used jointly across the spectrum of care seems critical to best capture changes related to NBB and develop better treatments.
Objective: To provide an overview of clinical assessments and diagnostic tools, self-report measures (SRMs) and data sets used in neurogenic bladder and bowel (NBB) dysfunction and recommendations for their use with persons with spinal cord injury /disease (SCI/D). Methods: Experts in SCI/D conducted literature reviews, compiled a list of NBB related assessments and measures, reviewed their psychometric properties, discussed their use in SCI/D and issued recommendations for the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements (CDEs) guidelines. Results: Clinical assessments included 15 objective tests and diagnostic tools for neurogenic bladder and 12 for neurogenic bowel. Following a two-phase evaluation, eight SRMs were selected for final review with the Qualiveen and Short-Form (SF) Qualiveen and the Neurogenic Bowel Dysfunction Score (NBDS) being recommended as supplemental, highly-recommended due to their strong psychometrics and extensive use in SCI/D. Two datasets and other SRM measures were recommended as supplemental. Conclusion: There is no one single measure that can be used to assess NBB dysfunction across all clinical research studies. Clinical and diagnostic tools are here recommended based on specific medical needs of the person with SCI/D. Following the CDE for SCI studies guidelines, we recommend both the SF-Qualiveen for bladder and the NBDS for bowel as relatively short measures with strong psychometrics. Other measures are also recommended. A combination of assessment tools (objective and subjective) to be used jointly across the spectrum of care seems critical to best capture changes related to NBB and develop better treatments.
Authors: J Christian Winters; Roger R Dmochowski; Howard B Goldman; C D Anthony Herndon; Kathleen C Kobashi; Stephen R Kraus; Gary E Lemack; Victor W Nitti; Eric S Rovner; Alan J Wein Journal: J Urol Date: 2012-10-24 Impact factor: 7.450
Authors: Abolghasem Nikfallah; Saeed Rezaali; Nooredin Mohammadi; Mahboobeh Abrishamkar; Ehsan Rezaei; Mohammad Ali Sahraian; Amir H Pakpour; Mir Saeed Yekaninejad Journal: Low Urin Tract Symptoms Date: 2014-03-11 Impact factor: 1.592
Authors: Jennifer M Pires; Ana M Ferreira; Filipa Rocha; Luis G Andrade; Inês Campos; Paulo Margalho; Jorge Laíns Journal: Eur J Phys Rehabil Med Date: 2018-05-09 Impact factor: 2.874
Authors: Charles H Hubscher; Jennifer Wyles; Anthony Gallahar; Kristen Johnson; Andrea Willhite; Susan J Harkema; April N Herrity Journal: Arch Phys Med Rehabil Date: 2020-12-03 Impact factor: 3.966
Authors: Chor Yin Lam; Paul Aarne Koljonen; Christopher Chun Hei Yip; Ivan Yuen Wang Su; Yong Hu; Yat Wa Wong; Kenneth Man Chee Cheung Journal: Front Neurol Date: 2022-08-03 Impact factor: 4.086